Cargando…

A Novel Predictive Multi-Marker Test for the Pre-Surgical Identification of Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer remains one of the most lethal malignancies for women, with a complex presentation and, typically, a late-stage diagnosis. Many common benign gynecological diseases can present with similar symptoms to malignancy, and exploratory surgery is required before a conclusive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stephens, Andrew N., Hobbs, Simon J., Kang, Sung-Woon, Bilandzic, Maree, Rainczuk, Adam, Oehler, Martin K., Jobling, Tom W., Plebanski, Magdalena, Allman, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650329/ https://www.ncbi.nlm.nih.gov/pubmed/37958440 http://dx.doi.org/10.3390/cancers15215267

Ejemplares similares

Keratin-14 (KRT14) Positive Leader Cells Mediate Mesothelial Clearance and Invasion by Ovarian Cancer Cells
por: Bilandzic, Maree, et al.
Publicado: (2019)

Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer
por: Kang, Sung-Woog, et al.
Publicado: (2021)

Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2018)

Chemoresistance is mediated by ovarian cancer leader cells in vitro
por: Karimnia, Nazanin, et al.
Publicado: (2021)

Hypoxia Regulates DPP4 Expression, Proteolytic Inactivation, and Shedding from Ovarian Cancer Cells
por: Moffitt, Laura R., et al.
Publicado: (2020)

DPP4 Inhibitor Sitagliptin Enhances Lymphocyte Recruitment and Prolongs Survival in a Syngeneic Ovarian Cancer Mouse Model
por: Wilson, Amy L., et al.
Publicado: (2021)

Pre-operative sera interleukin-6 in the diagnosis of high-grade serous ovarian cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2020)

Therapeutic Targeting of Collective Invasion in Ovarian Cancer
por: Moffitt, Laura, et al.
Publicado: (2019)

Mapping Epitopes Recognised by Autoantibodies Shows Potential for the Diagnosis of High-Grade Serous Ovarian Cancer and Monitoring Response to Therapy for This Malignancy
por: Moody, Rhiane, et al.
Publicado: (2021)

Ovarian Blood Sampling Identifies Junction Plakoglobin as a Novel Biomarker of Early Ovarian Cancer
por: Weiland, Florian, et al.
Publicado: (2020)

Diagnostic Value of Plasma Annexin A2 in Early-Stage High-Grade Serous Ovarian Cancer
por: Lokman, Noor A., et al.
Publicado: (2021)

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
por: Bilandzic, Maree, et al.
Publicado: (2014)

The Development of Nanoparticles for the Detection and Imaging of Ovarian Cancers
por: Henderson, Edward, et al.
Publicado: (2021)

Total PC Activity Is Increased in Uterine Lavage of Post-Menopausal Endometrial but Not Ovarian Cancer Patients
por: Heng, Sophea, et al.
Publicado: (2016)

Sperm Protein 17 Expression by Murine Epithelial Ovarian Cancer Cells and Its Impact on Tumor Progression
por: Gao, Qian, et al.
Publicado: (2018)

Regulatory T Cells in Ovarian Carcinogenesis and Future Therapeutic Opportunities
por: Cassar, Emily, et al.
Publicado: (2022)

Combination of hydrogel nanoparticles and proteomics to reveal secreted proteins associated with decidualization of human uterine stromal cells
por: Paule, Sarah, et al.
Publicado: (2011)

Substantially Modified Ratios of Effector to Regulatory T Cells During Chemotherapy in Ovarian Cancer Patients Return to Pre-Treatment Levels at Completion: Implications for Immunotherapy
por: Park, Anthony, et al.
Publicado: (2012)

Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2017)

Paclitaxel and Its Evolving Role in the Management of Ovarian Cancer
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2015)

Elevated Interleukin-6 Levels in the Circulation and Peritoneal Fluid of Patients with Ovarian Cancer as a Potential Diagnostic Biomarker: A Systematic Review and Meta-Analysis
por: Amer, Hina, et al.
Publicado: (2021)

Isolation and Characterization of Tumor Cells from the Ascites of Ovarian Cancer Patients: Molecular Phenotype of Chemoresistant Ovarian Tumors
por: Latifi, Ardian, et al.
Publicado: (2012)

Nucleosome footprinting in plasma cell-free DNA for the pre-surgical diagnosis of ovarian cancer
por: Vanderstichele, Adriaan, et al.
Publicado: (2022)

Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression
por: Cox, Momodou, et al.
Publicado: (2021)

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system
por: Bound, Nirashaa T., et al.
Publicado: (2022)

TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells
por: Escalona, Ruth M., et al.
Publicado: (2020)

Measuring PC activity in endocervical swab may provide a simple and non-invasive method to detect endometrial cancer in post-menopausal women
por: Heng, Sophea, et al.
Publicado: (2016)

Decidual-Secreted Factors Alter Invasive Trophoblast Membrane and Secreted Proteins Implying a Role for Decidual Cell Regulation of Placentation
por: Menkhorst, Ellen Melaleuca, et al.
Publicado: (2012)

Laparoscopic Surgical Management and Clinical Characteristics of Ovarian Fibromas
por: Son, Chang Eop, et al.
Publicado: (2011)

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2023)

Editorial: The Role of TNF-TNFR2 Signal in Immunosuppressive Cells and Its Therapeutic Implications
por: Chen, Xin, et al.
Publicado: (2019)

Editorial: The role of TNF-TNFR2 signal in immunosuppressive cells and its therapeutic implications, volume II
por: Chen, Xin, et al.
Publicado: (2023)

A Novel Approach for Non-Invasive Lung Imaging and Targeting Lung Immune Cells
por: Chakraborty, Amlan, et al.
Publicado: (2020)

Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling
por: Samardzija, Chantel, et al.
Publicado: (2017)

Comparison of Interleukin-6 with Other Markers in Diagnosis of Ovarian Cancer
por: Bizoń, Magdalena, et al.
Publicado: (2023)

Parents Need More Support: A Qualitative Study of the Experiences of Australian Parents Who Are Waiting for Surgical Intervention for Their Children With Otitis Media
por: Stephens, Jacqueline H, et al.
Publicado: (2019)

Pre-surgical peripheral blood inflammation markers predict surgical site infection following mesh repair of groin hernia
por: Zhuo, Yeye, et al.
Publicado: (2021)

Epithelial Ovarian Cancer and the Immune System: Biology, Interactions, Challenges and Potential Advances for Immunotherapy
por: Macpherson, Anne M., et al.
Publicado: (2020)

Utilizing Ion Mobility-Mass Spectrometry to Investigate the Unfolding Pathway of Cu/Zn Superoxide Dismutase
por: Butler, Karen E., et al.
Publicado: (2021)

Label-Free Quantification Mass Spectrometry Identifies Protein Markers of Chemotherapy Response in High-Grade Serous Ovarian Cancer
por: Arentz, Georgia, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0tedicn5mlf3opn3ak69tc9n9c